MyFinsight
Home
Compare
About
Recent SEC Filings
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$1,378K
Free Cash flow
-$8,138K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Stock-based compensation expense
Accounts payable
Others
Negative Cash Flow Breakdown
Accrued liabilities
Prepaid expenses
Other receivables
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Net loss
-9,442
-9,243
-28,759
Depreciation of property and equipment
15
16
70
Non-cash lease expense
71
73
288
Stock-based compensation expense
1,788
2,299
3,104
Value of shares issued to consultants
657
730
3,467
Unrealized foreign exchange loss
-7
-13
137
Change in fair value of warrant derivative
0
0
-153
Fair value loss from sepa arrangement
0
-
-388
Value of shares issued for sepa arrangement commitment fees
0
-
440
Other receivables
253
388
-3
Prepaid expenses
742
155
-580
Accounts payable
730
-813
2,932
Accrued liabilities
-894
249
-360
Pancreatic cancer action network (pancan) receivables and payables
-
-
-1,682
Operating lease liabilities
-75
-74
-293
Net cash used in operating activities
-8,138
-7,293
-20,112
Acquisition of property and equipment
0
6
6
Net cash used in investing activities
0
-6
-6
Proceeds from exercise of warrant derivative
-
-
0
Proceeds from issuance of common stock-At The Market Offering Agreement
14,385
-
11,767
Proceeds from issuance of common stock-Standby Equity Purchase Agreement
0
-
2,348
Proceeds from stock option exercise
-
-
32
Other
-
-
-27
Proceeds from at-the-market offering agreements, net of issuance costs
-
7,614
-
Net cash provided by financing activities
6,771
7,614
14,120
Effect of exchange rate changes on cash and cash equivalents
-11
-24
121
Net decrease in cash and cash equivalents
-1,378
291
-5,877
Cash and cash equivalents, beginning of period
5,493
5,202
11,079
Cash and cash equivalents, end of period
4,115
5,493
5,202
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
ONCY Cash Flow Sankey Diagram
Sankey diagram visualizing ONCY cash flow for the period
Proceeds from issuance of
common stock-At The...
$14,385K
Net cash provided by
financing activities
$6,771K
Canceled cashflow
$7,614K
Net decrease in cash
and cash...
-$1,378K
Canceled cashflow
$6,771K
Stock-based compensation
expense
$1,788K
Accounts payable
$730K
Value of shares issued
to consultants
$657K
Non-cash lease expense
$71K
Depreciation of property and
equipment
$15K
Unrealized foreign
exchange loss
-$7K
something is missing
-$7,614K
Net cash used in
operating activities
-$8,138K
Canceled cashflow
$3,268K
Effect of exchange rate
changes on cash and cash...
-$11K
Net loss
-$9,442K
Accrued liabilities
-$894K
Prepaid expenses
$742K
Other receivables
$253K
Operating lease
liabilities
-$75K
Buy us a coffee
ONCOLYTICS BIOTECH INC (ONCY)
ONCOLYTICS BIOTECH INC (ONCY)